Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis, corresponding compositions and kits

Details for Australian Patent Application No. 2009201892 (hide)

Owner Metheresis Translational Research S.A.

Inventors Van Dongen, Guus; Comoglio, Paolo Maria; Carminati, Paolo

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009201892

Priority 08157163.0 29.05.08 EP

Filing date 13 May 2009

Wipo publication date 17 December 2009

International Classifications

G01N 33/534 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with radioactive label

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/00 (2006.01) Mutation or genetic engineering

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

28 May 2009 Complete Application Filed

  Priority application(s): 08157163.0 29.05.08 EP

17 December 2009 Application Open to Public Inspection

  Published as AU-A-2009201892

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201893-High affinity binding site of HGFR and methods for identification of antagonists thereof

2009201891-Valve connector for medical lines